NCT06455722 2024-06-12
[68Ga]Ga-P15-041 PET/CT in Variety of Bone Tumors
First Affiliated Hospital of Fujian Medical University
Phase EARLY_PHASE1 Unknown
Clinical Trials
303 trialsNCT05899751 2024-05-10
Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate
BTG International Inc.
Unknown
NCT06291662 2024-03-04
Evaluation of Performance Characteristics and Applicability in Oncology of Devices Customized Medical Devices Made by 3D Printing
Meyer Children's Hospital IRCCS
Phase NA Unknown
NCT03462888 2024-02-09
RMS-AJA-1701
Centre Oscar Lambret
Unknown
NCT04149691 2024-02-07
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Celon Pharma SA
Phase 1 Unknown
NCT04842071 2024-02-07
18F-sodium Fluoride (NaF) PET to Replace Bone Scintigraphy: Safety and Efficacy Assessment
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Phase 3 Unknown
NCT05189483 2024-02-07
Albumin-bound Paclitaxel Plus Camrelizumab for Advanced Soft Tissue Sarcoma.
Henan Cancer Hospital
Phase 2 Unknown
NCT05453409 2024-02-07
Study on Clinical Features, Treatment Mode and Survival of Sarcoma
Henan Cancer Hospital
Unknown
NCT05598229 2024-02-07
Application of Douyin in Perioperative Period of Malignant Tumor Patients
Henan Cancer Hospital
Phase NA Unknown
NCT05615545 2024-02-07
Cryoablation for Advanced Bone and Soft Tissue Tumors
Henan Cancer Hospital
Unknown
NCT05718778 2024-02-07
Piamprilizumab (AK105) Combined With Radiotherapy for Neoadjuvant Treatment of Soft Tissue Sarcoma
Henan Cancer Hospital
Phase NA Unknown
NCT03242382 2024-01-23
PalboSarc
Grupo Espanol de Investigacion en Sarcomas
Phase 2 Unknown
NCT06217003 2024-01-22
Trilaciclib Combined With Chemotherapy for Perioperative Treatment of Osteosarcoma
The First Affiliated Hospital of Xinxiang Medical College
Phase 2 Unknown
NCT06217224 2024-01-22
PBMT/MTX
Instituto Nacional de Cancer, Brazil
Phase NA Unknown
NCT04442373 2024-01-17
I-SIGHT-THR
Medical University of Warsaw
Unknown
NCT01541709 2024-01-02
Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI
Asan Medical Center
Phase 2 Unknown
NCT06186986 2024-01-02
CD30 Imaging in Diffuse Large B-cell Lymphoma
University Medical Center Groningen
Phase 3 Unknown
NCT04025931 2023-12-29
Chidamide Combined With Toripalimab in Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT05549921 2023-12-27
Phase II Study of TAEST16001 in Soft Tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT04927260 2023-12-26
AVIATOR2020
Centre Leon Berard
Unknown
NCT01811394 2023-12-06
ISAC
Heidelberg University
Phase 2 Unknown
NCT03600649 2023-11-21
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas
Salarius Pharmaceuticals, LLC
Phase 1 Unknown
NCT06140732 2023-11-20
Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma
Xuanwu Hospital, Beijing
Phase 2 Unknown
NCT04198337 2023-11-07
EFTR
Chinese University of Hong Kong
Phase NA Unknown
NCT06117878 2023-11-07
Safety and Efficacy of NK510 to Treat Osteosarcoma and Soft Tissue Sarcoma
Base Therapeutics (Shanghai) Co., Ltd.
Phase EARLY_PHASE1 Unknown
NCT05094804 2023-11-02
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
OncoResponse, Inc.
Phase 1/2 Unknown
NCT06113094 2023-11-02
CARDT
University Hospital, Strasbourg, France
Unknown
NCT06114173 2023-11-02
Efficacy and Safety Study of Cardunilizumab in Soft Tissue Sarcoma
Xiangya Hospital of Central South University
Phase EARLY_PHASE1 Unknown
NCT03742193 2023-11-01
PROACH
Ruijin Hospital
Phase 2 Unknown
NCT04893356 2023-10-30
MGMT
National Cancer Institute, Naples
Unknown
NCT05490667 2023-10-30
Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor
Henan Cancer Hospital
Phase NA Unknown
NCT04308330 2023-10-26
NYMC195
New York Medical College
Phase 1 Unknown
NCT03420014 2023-10-10
FIBROSARC US
Philogen S.p.A.
Phase 2 Unknown
NCT06076070 2023-10-10
PROGEN_SARC
Regina Elena Cancer Institute
Unknown
NCT05453292 2023-09-28
Endoscopic Ultrasound Radiofrequency Ablation for GISTs
Instituto Ecuatoriano de Enfermedades Digestivas
Phase NA Unknown
NCT05448820 2023-09-21
YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma
Tracon Pharmaceuticals Inc.
Phase 1/2 Unknown
NCT04367779 2023-09-13
PROTONBIOMARKS
Centre Leon Berard
Unknown
NCT04741438 2023-08-30
RAR-Immune
Centre Leon Berard
Phase 3 Unknown
NCT06008483 2023-08-23
A Dose Finding Study to Treat Bone Tumor(s)
QSAM Therapeutics, Inc.
Phase 1 Unknown
NCT04510714 2023-08-03
BORIS
Instituto do Cancer do Estado de São Paulo
Phase NA Unknown
NCT03890068 2023-08-01
Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT05266196 2023-08-01
A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)
Salarius Pharmaceuticals, LLC
Phase 1/2 Unknown
NCT05963035 2023-07-27
Clinical Application of 18F-PFPN PET Imaging in Diagnosis and Staging of Clear Cell Sarcoma of Soft Tissue
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase NA Unknown
NCT05707767 2023-07-19
A Prospective Study of Surgical Treatment Strategies for Chordoma
Xuanwu Hospital, Beijing
Phase NA Unknown
NCT05952128 2023-07-19
Phase Ib/II Study of Fluzoparib in Combination With Dalpiciclib in Patients With Locally Advanced or Metastatic Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT05708950 2023-07-13
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Phase 1/2 Unknown
NCT02365441 2023-07-07
ALT GIST
Australasian Gastro-Intestinal Trials Group
Phase 2 Unknown
NCT05895942 2023-06-09
EMMBKM
Xijing Hospital
Unknown
NCT05886075 2023-06-02
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown
NCT05487651 2023-05-18
ANCHOR2
Athenex, Inc.
Phase 1 Unknown